|
|
 |
|
Viewing report
|
|
|
|
Iran Pharmaceutical Market Review, 2004-2008
Iran Pharmaceutical Consulting Services, March 2010, Pages: 185
Iran's pharmaceutical industry has developed significantly over the last few decades. Expansion of healthcare facilities within the country and the rapid pharmaceutical market growth, in addition to the high population (exceeding 73 million) with rising demand for health care and pharmaceutical products, has made Iran a highly attractive market for business. Its fast growing market has triggered an escalating competition both by local manufacturers and by international firms in recent years. With 25% annual growth, the value of the market reached US$2.3 billion in 2008 and sustained an average growth of 23% for four consecutive years from 2005 to 2008.
Analyzed in a five-year period (2004-2008), this report provides you with the latest detailed information available on the pharmaceutical market of Iran and allows you to investigate trends in its different segments. Summing up both import and local manufacturing data, it gives you a comprehensive image of the total market. Furthermore, its factual approach makes the report an essential reference for decision makers in pharmaceutical companies that are interested to enter and expand their business in Iran and benefit from its lucrative opportunities.
This Iran Pharmaceutical Consulting Services report is presented in 16 chapters and has categorized information in two standpoints:
1 Total market review
In this section detailed historic information is provided, some of which are market size by anatomical main groups classified based on Anatomical Therapeutic Chemical (ATC) Classification System, market top 10 classes in terms of value by second, third and forth level of ATC, market main dosage forms, top 20 pharmaceutical molecules and top 20 products.
2 Market analysis by anatomical main groups of ATC
The report segments market into 14 anatomical main groups of ATC, including:
1. Alimentary tract and metabolism
2. Blood and blood forming organs
3. Cardiovascular system
4. Dermatologicals
5. Genitourinary system and sex hormones
6. Systemic hormonal preparations (excluding sex hormones and insulins)
7. Anti-infectives for systemic use
8. Antineoplastic and immunomodulating agents
9. Musculoskeletal system
10. Nervous system
11. Antiparasitic products, insecticides and repellents
12. Respiratory system
13. Sensory organs
14. Various
For each of above groups, detailed historic information is provided some of which are main therapeutic groups, main dosage forms, top 10 pharmaceutical molecules, and top 10 products.
Please note:
- This report only includes finished product market and does not cover raw materials and intermediary market.
- This report excludes dietary supplement market.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Iran Pharmaceutical Local Manufacturing Market Review, 2004-2008
Iran Pharmaceutical Import Market Review, 2004-2008
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013
Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
Iran Healthcare and Pharmaceuticals Overview
Commercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phase
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
Blood Banking & Blood Products - Global Strategic Business Report
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009
|
|
|
|
